Sutro Biopharma's IPO

Sutro Biopharma raised a round of funding on September 27, 2018. Investors include Public.

Sutro Biopharma is a clinical stage drug discovery, development and manufacturing company focused on leveraging its integrated cell-free protein synthesis platform, XpressCF, to create a broad variety…

Articles about Sutro Biopharma's IPO: